Insurers' Short Term Thinking Harms Patients
By Peter Pitts
When 41-year-old New Jersey resident Amy Speicher was diagnosed with advanced skin cancer, she feared the disease -- and the hair loss, vomiting, and crippling fatigue that usually come with cancer treatment.
None of that came to pass. Speicher sailed through her treatment, balancing parenting and a full-time job. How? Her insurance paid for a groundbreaking immunotherapy, which has far fewer side effects than run-of-the-mill chemo.